Back
Evans Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
54
EVBN
Evans Bancorp
Last Price:
$39.53
Seasonality Move:
1.43%
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
$36.26
Seasonality Move:
13.8%
Buy
54
Evans Bancorp (EVBN)
is a Buy
Is Evans Bancorp a Buy, Sell or Hold?
-
The current Evans Bancorp [EVBN] share price is $39.53. The Score for EVBN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
EVBN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $36.27. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVBN Stock Price Chart
What is Evans Bancorp's stock price today?
-
The Evans Bancorp share price today is $39.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVBN is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $36.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
EVBN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 61.06 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.58 - 38.84) | Buy |
| Bollinger Bands (100): | (38.27 - 44.25) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.02 | Sell |
| Relative Strength Index (14 RSI): | 22.68 | Sell |
| Chaikin Money Flow: | -5425494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.24 - 62.32) | Sell |
| Bollinger Bands (100): | (65.54 - 121.78) | Sell |
EVBN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.86 | Buy |
| 20-day SMA: | 37.14 | Buy |
| 50-day SMA: | 38.87 | Buy |
| 200-day SMA: | 39.62 | Sell |
| 8-day EMA: | 38.73 | Buy |
| 20-day EMA: | 38.09 | Buy |
| 50-day EMA: | 38.88 | Buy |
| 200-day EMA: | 38.53 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.08 | Sell |
| 20-day SMA: | 54.75 | Sell |
| 50-day SMA: | 69.96 | Sell |
| 200-day SMA: | 111.27 | Sell |
| 8-day EMA: | 46.82 | Sell |
| 20-day EMA: | 54.19 | Sell |
| 50-day EMA: | 68.41 | Sell |
| 200-day EMA: | 100.79 | Sell |
Evans Bancorp Earnings Growth & EVBN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.87 per share, a decrease this year of $3.97 per share, and an increase next year of $8.43 per share.
Evans Bancorp Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||